Triasima Portfolio Management inc. cut its stake in Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS) by 18.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,603 shares of the technology company’s stock after selling 17,172 shares during the period. Celestica makes up approximately 2.8% of Triasima Portfolio Management inc.’s investment portfolio, making the stock its 5th biggest position. Triasima Portfolio Management inc.’s holdings in Celestica were worth $18,608,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CLS. NorthCrest Asset Manangement LLC boosted its position in shares of Celestica by 322.1% during the 3rd quarter. NorthCrest Asset Manangement LLC now owns 13,170 shares of the technology company’s stock valued at $3,132,000 after purchasing an additional 10,050 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its position in Celestica by 130.3% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 20,807 shares of the technology company’s stock worth $4,948,000 after buying an additional 11,772 shares during the last quarter. Intrua Financial LLC increased its holdings in shares of Celestica by 10.2% in the third quarter. Intrua Financial LLC now owns 3,990 shares of the technology company’s stock valued at $983,000 after buying an additional 369 shares in the last quarter. Glass Jacobson Investment Advisors llc acquired a new stake in shares of Celestica during the 3rd quarter valued at $206,000. Finally, Yorktown Management & Research Co Inc acquired a new stake in shares of Celestica during the 3rd quarter valued at $604,000. Institutional investors own 67.38% of the company’s stock.
Analyst Upgrades and Downgrades
CLS has been the topic of a number of recent analyst reports. The Goldman Sachs Group boosted their target price on Celestica from $340.00 to $440.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. UBS Group upped their price objective on shares of Celestica from $208.00 to $350.00 and gave the company a “neutral” rating in a research note on Wednesday, October 29th. CIBC lifted their target price on shares of Celestica from $315.00 to $400.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Weiss Ratings restated a “buy (b)” rating on shares of Celestica in a report on Wednesday, October 8th. Finally, Wall Street Zen lowered shares of Celestica from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $336.13.
Celestica Stock Performance
NYSE:CLS opened at $307.79 on Tuesday. Celestica, Inc. has a fifty-two week low of $58.05 and a fifty-two week high of $363.40. The company has a 50 day simple moving average of $310.52 and a two-hundred day simple moving average of $258.58. The company has a market capitalization of $35.41 billion, a PE ratio of 49.34 and a beta of 1.87. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.88 and a current ratio of 1.47.
Celestica (NYSE:CLS – Get Free Report) (TSE:CLS) last issued its quarterly earnings results on Monday, October 27th. The technology company reported $1.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.45 by $0.13. Celestica had a return on equity of 30.53% and a net margin of 6.35%.The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.01 billion. During the same period last year, the business posted $1.04 EPS. The business’s revenue was up 27.8% compared to the same quarter last year. Research analysts anticipate that Celestica, Inc. will post 4.35 earnings per share for the current year.
Insider Buying and Selling at Celestica
In related news, Director Laurette T. Koellner bought 6,000 shares of the company’s stock in a transaction that occurred on Thursday, October 30th. The shares were bought at an average price of $341.67 per share, for a total transaction of $2,050,020.00. Following the transaction, the director directly owned 6,000 shares of the company’s stock, valued at approximately $2,050,020. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.52% of the stock is owned by corporate insiders.
About Celestica
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Featured Articles
- Five stocks we like better than Celestica
- Wall Street Alert: Buy AES
- Your Bank Account Is No Longer Safe
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- Trump’s AI Secret: 100X Faster Than Nvidia
- Trump Did WHAT??
Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS).
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.
